The conducted research shows that some inborn gene mutations, such as the GSTM1-null phenotype (Glutathione S-Transferase Mu 1) or the CDH1 gene (Cadherin-1), increase the risk of developing GC. This evidence concerns the gene GSTM1 and gastric cancer.